Most patients with chemotherapy-induced febrile neutropenia recover rapidly without serious complications. However, it remains life-threatening, treatment-related toxicity and correlates with chemotherapy dose reductions and delays in continuing chemotherapy, potentially compromising treatment outcomes, leading to shock and death.